Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
GMP Review is Scopus-indexed (Q4, CiteScore 0.1). Published by Euromed Communications.
Checked against the index lists dated .
ISSN 1476-4547Verify ISSN ↗
Publisher: Euromed Communications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 183 / 191 | 4th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present (also 2011–2015), best quartile Q4, CiteScore 0.1.
GMP Review is Q4 in Pharmaceutical Science (rank 183 of 191), by CiteScore 2025.
GMP Review is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 4th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.102, quartile Q4, with an H-index of 3.
GMP Review is published by Euromed Communications. Its ISSN is 1476-4547.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.